Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors

NCT02573272 · clinicaltrials.gov ↗
UNKNOWN
Status
204
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud